Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to Higher-Valent Options in Greek Infants

por Warren, Sophie, Barmpouni, Myrto, Kossyvaki, Vasiliki, Gourzoulidis, George, Perdrizet, Johnna
Publicado 2023

Health and economic outcomes of 20-valent pneumococcal conjugate vaccine compared to 15-valent pneumococcal conjugate vaccine strategies for adults in Greece

por Gourzoulidis, George, Barmpouni, Myrto, Kossyvaki, Vasiliki, Vietri, Jeffrey, Tzanetakos, Charalampos
Publicado 2023

Clinical and Economic Value of Reducing Antimicrobial Resistance in the Management of Hospital-Acquired Infections with Limited Treatment Options in Greece

por Barmpouni, Myrto, Gordon, Jason P., Miller, Ryan L., Dennis, James W., Grammelis, Vassilis, Rousakis, Aris, Souliotis, Kyriakos, Poulakou, Garyphallia, Daikos, George L., Al-Taie, Amer
Publicado 2023

Estimating the Clinical and Economic Impact of Introducing a New Antibacterial into Greek Clinical Practice for the Management of Hospital-Acquired Infections with Limited Treatmen...

por Barmpouni, Myrto, Gordon, Jason P., Miller, Ryan L., Pritchard, Clive R. J., Dennis, James W., Grammelis, Vassilis, Rousakis, Aris, Souliotis, Kyriakos, Poulakou, Garyphallia, Daikos, George L., Al-Taie, Amer
Publicado 2022